Le Lézard2 天
Navega Therapeutics Announces CIRM Grant for Treatment of Chronic Pain
Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant from CIRM for the relief of neuropathic pain.
Tariff Retaliation Begins as Trump Acknowledges ‘Pain’ Is Possible
The authorities could allow the country’s currency, the peso, to weaken against the dollar, effectively making its exports ...
The Sentinel-Record5 天
FDA OKs painkiller designed to eliminate the risk of addiction
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.
What Is Journavx, A New Non-opioid Pain Reliever Approved By FDA in Decades?
The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...
Richmond6 天
FDA approves new painkiller that shows promise and challenges of opioid alternatives
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
BioPharma Dive6 天
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...